Related Experiment Videos
Acute hepatitis associated with montelukast
Journal of Hepatology
|April 26, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19.
Proceedings of the National Academy of Sciences of the United States of America·2025
Cardiotoxicity Associated with Venlafaxine-Defining Features in a Series of Five Cases and a Call for Proactive Monitoring.
Journal of clinical medicine·2025
Mottling as an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors.
European journal of case reports in internal medicine·2025
Proactive Geriatric Medication Management and Deprescribing Efforts in Swiss Nursing Home Residents.
Journal of clinical medicine·2025
An in vivo microscopy dataset for the characterization of leukocyte death.
Scientific data·2025
IgA-Enriched Phenotype Predicts Liver-Related Events in MASLD.
Journal of hepatology·2026
Setdb1 represses anti-tumor immunity and tertiary lymphoid structures in hepatocellular carcinoma.
Journal of hepatology·2026
Surveillance of patients at risk of liver cancer: Expert opinions.
Journal of hepatology·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.
Frontiers in genetics·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026